Answers are grounded in this paper and cite their sources.
Shows diet-induced changes in microbiome and inflammation in mice, suggesting therapeutic potential for microbiome-related diseases.
Gut microbiome composition has been frequently but inconsistently associated with human disease. Using a food dye-based gastrointestinal (GI) passage assay to measure GI transit time, stool production (fecal mass), fecal microbiota density (microbial load), and absolute microbiota proliferation (fecal microbiota excretion) in mice, we show quantitative microbiome parameters (QMPs) to be controlled by diet, feeding pattern, and IL-10 deficiency, with food intake and GI transit time acting as separate modulators. High-fiber diet (HFiD) and time-restricted feeding (TRF) reduce GI transit time and induce convergent QMP reductions, whereas high-fat diet (HFaD) produces contrary effects. Intestinal gene expression signatures are consistent with the described shared anti-inflammatory effects of HFiD and TRF, which sharply contrast differences in fecal taxonomic microbiota profiles that are explained by ecological and experimental confounders. Similar QMP and gene expression modulations by distinct diet and feeding interventions warrant exploration of a diagnostic and therapeutic QMP potential for microbiome-mediated disease.
No takes yet. Share an insight, caveat, or question.
Ruple et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: